NCT03889912
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03889912
Title Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | AUS

Facility Status City State Zip Country Details
Medical Dermatology Specialists Phoenix Arizona 85006 United States Details
TCR Medical Corporation San Diego California 92123 United States Details
Dermatology Associates of the Palm Beaches Delray Beach Florida 33445 United States Details
MetroDerm Atlanta Georgia 30342 United States Details
Northeast Dermatology Associates Beverly Massachusetts 01915 United States Details
Rochester Dermatologic Surgery, P.C. Victor New York 14564 United States Details
Duke Cancer Center Durham North Carolina 27710 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
Princess Alexandra Hospital Brisbane Queensland 4102 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Health Melbourne Victoria 3004 Australia Details
Fremantle Dermatology Fremantle Western Australia 6160 Australia Details
Radboud University Medical Center Nijmegen Gelderland 6500 HB Netherlands Details
Maastricht University Medical Center Maastricht Limburg 6202 AZ Netherlands Details
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Amsterdam North Holland 1066 CX Netherlands Details
University of Groningen, University Medical Centre Groningen Groningen 9700 RB Netherlands Details
Erasmus MC Rotterdam 3015 GD Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field